Fingerprint
Dive into the research topics of 'A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically